CrushSCI.com
Journal Selection & Manuscript Polishing Services
Archives of Cardiovascular Diseases journal cover Medicine
Back to journal directory

Review Cycle Records

Archives of Cardiovascular Diseases

Elsevier SCIE Non-OA
2026 Emerging Zone 32025 CAS Zone 42025 JCR Q2
153.3Average days
134Median days
34Fastest days
337Longest days
6312025 publications

Paper Review Records

All Paper Review Records

10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

34 days

Experts’ recommendations for the management of adult patients with cardiogenic shock

AuthorsNadia Aissaoui; Clement Delmas; Hamid Merdji; Guillaume Schurtz; Guillaume Baudry; Antoine Beurton; Florence Boissier; Laurent Bonello; Bernard Cholley; Nicolas Combaret; Alain Combes; Charles-Henri David; Daniel De Backer; Pierre Grégoire Guinot; Olfa Hamzaoui; Brahim Harbaoui; Julien Imbault; Nicolas Nesseler; Antoine Kimmoun; Michel Kindo; Guillaume Lebreton; Guillaume Leurent; Bruno Levy; Stéphane Manzo-Silberman; Anne-Céline Martin; Armand Mekontso-Dessap; Imane Adda; Joy Mootien; Alexandre Ouattara; Matteo Pozzi; Etienne Puymirat; Francois Roubille; Antonin Trimaille; Aurore Ughetto; Eric Van Belle; Eric Bonnefoy; Khaldoun Kuteifan

AffiliationsIntensive Cardiac Care Unit, Cardiology department, Hôpital européen Georges-Pompidou, Assistance publique des Hôpitaux de Paris, Université Paris Cité, Paris, France; Intensive Cardiac Care Unit, Cardiology Department, Toulouse University Hospital, Toulouse University, Inserm, UMR 1297, Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Toulouse, France; REICATRA, Institut Saint-Jacques, Toulouse, France; Department of Medical Intensive Care, University Hospital of Strasbourg, Nouvel Hôpital Civil, Inserm (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine (RNM), FMTS, Strasbourg, France; Cardiac Intensive Care Unit, Institut Cœur Poumon, CHU de Lille, Lille, France; Université de Lorraine, Inserm, Centre d’Investigation Clinique Plurithématique 1433, Inserm U1116, CHRU de Nancy, Nancy, France; INI-CRCT (Cardiovascular and Renal Clinical Trialists) F-CRIN Network, REICATRA, Nancy, France; Department of Cardiovascular Anesthesia and Critical Care, CHU de Bordeaux, 33000 Bordeaux, France; Université de Bordeaux, Inserm, BMC, U1034, 33600 Pessac, France; CHU de Poitiers, Médecine Intensive-Réanimation, Poitiers, France; Inserm, Centre d’investigation Clinique (CIC) 14-02 IS-ALIVE, Université de Poitiers, 86000 Poitiers, France; Unite de soins intensifs de cardiologie, Hôpital nord de Marseille, Aix-Marseille université, 13015 Marseille, France; Service d’Anesthésie-Réanimation & Médecine Péri-Opératoire, Hôpital européen Georges-Pompidou, AP–HP, Paris, France; Inserm UMR-S1140, Université Paris Cité, Paris, France; Sorbonne Université, Inserm, UMRS_1166-ICAN, Institute of Cardiometabolism and Nutrition, AP–HP, Service de médecine intensive-réanimation, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, Paris, France; Nantes Université, CHU de Nantes, chirurgie thoracique et cardiovasculaire, l’institut du thorax, 44000 Nantes, France; Department of Intensive Care, CHIREC Hospitals, Université Libre de Bruxelles, Brussels, Belgium; Department of Anesthesiology and Intensive Care, Dijon University Hospital, University of Burgundy Europe, LNC UMR1231, 21000 Dijon, France; CHU de Reims, Unité de Médecine Intensive et Réanimation Polyvalente, Université de Reims Champagne-Ardenne, UR 3801 PPF, Reims, France; Interventional Cardiology Department, Hôpital Croix-Rousse, Hôpital Louis-Pradel, Hospices Civils de Lyon, Lyon, France; University of Lyon, CREATIS UMR5220, Inserm U1044, INSA-15, Lyon, France; Department of Anesthesia and Critical Care, Pontchaillou, University Hospital of Rennes, Université de Rennes, CHU de Rennes, Inserm, CIC 1414 (Centre d’Investigation Clinique de Rennes), Inrae, Institut NUMECAN – UMR_A 1341, UMR_S 1241, FHU SUPORT, 35000 Rennes, France; Université de Lorraine, CHRU de Nancy, Service de médecine intensive et réanimation Brabois, U1116, F-CRIN INI-CRCT, Nancy, France; Department of Cardiac Surgery, Hôpitaux Universitaires de Strasbourg, Nouvel Hôpital Civil, Strasbourg, France; Sorbonne Université, AP–HP, Service de chrirugie cardiaque, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, Paris, France; Department of Cardiology, Université Rennes 1, CHU de Rennes, Inserm, LTSI, UMR 1099, Rennes, France; Institut du Cœur et des Vaisseaux, CHU Nancy-Brabois, Groupe Choc, équipe 2, Inserm U1116, Faculté de Médecine, Nancy, France; AP–HP, Cardiology Department, Cardiology Institut, Hôpital Pitié-Salpêtrière, Paris, France; Sorbonne University, Inserm, UMRS_1166-ICAN, ACTION Study Group, Paris, France; Division of Cardiology, Advanced Heart Failure Unit, AP–HP, Hôpital européen Georges-Pompidou, 75015 Paris, France; Université Paris Cité, Inserm, PARCC, 75015 Paris, France; AP–HP, Hôpitaux Universitaires Henri-Mondor, Service de médecine intensive-réanimation, Université Paris Est Créteil, Inserm, Institut Mondor, CARMAS, 94010 Créteil, France; Department of Cardiac Surgery, Louis-Pradel Hospital, Lyon, France; Department of Research, One Clinic, PointGyn, Paris, France; Unité Fonctionnelle de Conseil en Antibiothérapie, CHU de Mulhouse, Mulhouse, France; Department of Cardiovascular Anesthesia and Critical Care, CHU de Bordeaux, Université de Bordeaux, Inserm, BMC, U1034, Bordeaux, France; Department of Cardiac Surgery, Louis-Pradel Hospital, Hospices Civils de Lyon, Research on Healthcare Performance Reshape, Inserm U1290, Université Claude-Bernard Lyon 1, Lyon, France; Assistance publique–Hôpitaux de Paris (AP–HP), Hôpital européen Georges-Pompidou, Department of Cardiology, 75015 Paris, France; PARCC, Université de Paris Cité, 75006 Paris, France; PhyMedExp, Cardiology Department, Université de Montpellier, Inserm, CNRS, INI-CRT, CHU de Montpellier, Montpellier, France; Department of Cardiovascular Medicine, Nouvel Hôpital Civil, 2UR 3074, Translational Cardiovascular Medicine Biomedicine Research Centre of Strasbourg, University of Strasbourg, Strasbourg, France; Department of Cardiothoracic Anesthesia and Critical Care Medicine, Montpellier University Hospital, Montpellier, France; Department of Cardiology, Louis-Pradel Hospital, Hospices Civils de Lyon, University of Lyon, INSA-Lyon, University Claude-Bernard Lyon 1, Lyon, France; Medical Intensive Care Unit, GHRMSA, Mulhouse, France

Source PDF DOI Publisher page
169 days

Impact of RNAi therapeutics on cardiac parameters in patients with hereditary transthyretin amyloidosis initially treated with stabilizers: A French real-world study

AuthorsAntoine Fraix; Vincent Algalarrondo; Olivier Lairez; Marie Arnal; Nicolas Piriou; Maud Michaud; Gilbert Habib; François Roubille; Claire Lucas; Antoine Jobbé Duval; Bérengère Bachelet; Erwan Donal; Thibaud Damy; Patricia Réant; Mounira Kharoubi; Olivier Huttin

AffiliationsCardiology Department, CHRU Nancy, Site Brabois, 54500 Vandœuvre, France; Referral centre for cardiac amyloidosis CERAMIC-Cardio, Cardiology Department, Bichat Hospital, AP–HP, 75018 Paris, France; Department of Cardiology, CHU de Toulouse, 31400 Toulouse, France; Department of Nuclear Medicine, CHU de Toulouse, 31400 Toulouse, France; Cardiac Imaging Centre, Medical School, CHU de Toulouse, Toulouse III Paul Sabatier University, 31400 Toulouse, France; Department of Cardiology, Bichat University Hospital, AP–HP, 75018 Paris, France; Inserm, Reference Centre for cardiomyopathies, CIC 1413, Thorax Institute, CHU de Nantes, Nantes University, 44000 Nantes, France; Cardiology Department, La Timone Hospital, AP-HM, 264, 13005 Marseille, France; Inserm, PhyMedExp, CNRS, Cardiology Department, CHU de Montpellier, Montpellier University, 34000 Montpellier, France; Inserm 1060 & 1407, Heart Failure Department, Clinical Investigation Centre, Civil Hospices of Lyon, University Claude-Bernard Lyon 1, 69000 Lyon, France; Inserm 1099, Department of Cardiology, LTSI, LTSI, CHU de Rennes, University of Rennes, 35000 Rennes, France; Inserm U955, IMRB, Department of Cardiology and French Referral Centre for Cardiac Amyloidosis, East Paris Creteil University, Henri-Mondor Hospital, AP–HP, 94000 Créteil, France; CIC-P 1401, University Hospital Centre of Bordeaux, Bordeaux University, 33000 Bordeaux, France

Source PDF DOI Publisher page
337 days

Tafamidis treatment in transthyretin cardiac amyloidosis: A retrospective cohort analysis of outcomes and associated factors

AuthorsJohanna Krief; Sylvain Aguilhon; Quentin Delbaere; Audrey Agullo; Caroline Padovani; Valentin Dupasquier; Christophe Hédon; Valentin Femenia; Nawel Aouni; Florence Leclercq; Jean-Luc Pasquie; Joana Pissarra; Lionel Moulis; Nicolas Chapet; François Roubille

AffiliationsDepartment of Cardiology, CHU of Montpellier, 34090 Montpellier, France; PhyMedExp, Inserm, CNRS, CHRU, Montpellier University, 34090 Montpellier, France; Department of Paediatric and Adult Congenital Cardiology, M3C National Reference Centre, CHU of Bordeaux, 33604 Pessac, France; Clinical Research and Epidemiology Unit, Montpellier University, CHU of Montpellier, 34090 Montpellier, France; Department of Clinical Pharmacy, Montpellier University, CHU of Montpellier, 34090 Montpellier, France

Source PDF DOI Publisher page
101 days

Myocardial work during various right ventricle load conditions in a paediatric population

AuthorsRamona Ghenghea; Pierrick Pyra; Yves Dulac; Aitor Guitarte; Paul Vignaud; Philippe Acar; Khaled Hadeed; Clement Karsenty

AffiliationsPediatric and Congenital Cardiology, Children's Hospital, CHU Toulouse, 31059 Toulouse, France; INSERM UMR 1048, équipe 8 – I2MC – Institut des Maladies Métaboliques et Cardiovasculaires, Paul Sabatier University, 31400 Toulouse, France; Clinique Pasteur, Cardiology Department, 31300 Toulouse, France

Source PDF DOI Publisher page
135 days

Direct procurement and ex-situ assessment of donor hearts after controlled circulatory death: A French national pilot study

AuthorsAli Akamkam; Maïra Gaillard; Simon Dang Van; Guillaume Gautier-Renard; Emeline Chu Van; Aurore Armand; Jean Christophe Venhard; Jacques Thes; Aurélien Vallée; Benoit Decante; Gaelle Cheisson; Corinne Antoine; Benoit Colsch; Julien Guihaire

AffiliationsDepartment of Adult Cardiac Surgery and Transplantation, Marie-Lannelongue Hospital, groupe hospitalier Paris Saint-Joseph, 133, avenue de la Résistance, 92350 Le Plessis-Robinson, France; Laboratory of Preclinical Research, Department of Research and Innovation, groupe hospitalier Paris Saint-Joseph, 92350 Le Plessis-Robinson, France; Inserm, UMR_S 999, hypertension pulmonaire: physiopathologie and innovation thérapeutique (HPPIT), ERN-LUNG, hôpital Bicêtre, AP–HP, hôpital Marie-Lannelongue (groupe hospitalier Paris Saint-Joseph), université Paris-Saclay, 92350 Le Plessis-Robinson, France; Department of Cardiovascular Surgery, University Hospital of Angers, 49933 Angers, France; Département médicaments et technologies pour la santé (MTS), MetaboHUB, CEA, INRAE, université Paris-Saclay, 91191 Gif-sur-Yvette, France; Hospital Coordination of Organ and Tissue Donations, University Hospital of Angers, 49933 Angers, France; Hospital Coordination of Organ and Tissue Donations, University Hospital of Tours, 2, boulevard Tonnellé, 37044 Tours, France; Department of Anesthesiology, Marie-Lannelongue Hospital, groupe hospitalier Paris Saint-Joseph, 92350 Le Plessis-Robinson, France; Department of Anesthesiology, University Hospital of Bicêtre, 94270 Le Kremlin-Bicêtre, France; Nephrology and Kidney Transplantation, Hospital Saint-Louis, 75010 Paris, France; Agence de la biomédecine, 93212 Saint-Denis La Plaine, France

Source PDF DOI Publisher page
132 days

Associated diseases and diuretic dosage to predict mortality in transthyretin amyloid cardiomyopathy

AuthorsVincent Algalarrondo; Olivier Lairez; Marion Narbeburu; Pauline Fournier; Jerome Costa; Francoise Pelcot; Agnes Farrugia; Isabelle Durand-Zaleski; Herve Lilliu; Mathilde Bartoli; Stephane Fievez; Jeremie Rudant; Agathe Coste; Charlotte Noirot Cosson; Pierre Alexandre Squara; Giorgia Canali; Bertrand de Neuville; Michel S. Slama; Philippe Charron; Thibaud Damy

AffiliationsReferral Center for Cardiac Amyloidosis CERAMIC-Cardio, AP–HP Bichat Hospital, Université Paris-Cité, 75018 Paris, France; Department of Cardiology, Rangueil University Hospital, 31400 Toulouse, France; Accenture, 75013 Paris, France; Department of Cardiology, Reims University Hospital, 51100 Toulouse, France; Association Française contre l’Amylose, 13006 Marseille, France; Paris University, CRESS, INSERM, INRA, AP–HP, Public Health Henri Mondor Hospital & URCEco, Hotel Dieu Hospital, 75004 Paris, France; Inbeeo, London, WC1 3JA, United Kingdom; Pfizer, 75014 Paris, France; AP–HP, Department of Genetics & Department of Cardiology, Referral Center for Hereditary or Rare Cardiac Diseases, Pitié-Salpêtrière Hospital, 75013 Paris, France; Sorbonne Université, INSERM, UMR_S 1166 and ICAN Institute for Cardiometabolism and Nutrition, 75013 Paris, France; Referral Center for Cardiac Amyloidosis, Mondor Amyloidosis Network, GRC Amyloid Research Institute and Cardiology Department, AP–HP Henri Mondor Hospital, 94000 Créteil, France; INSERM Unit U955, Team 8, Paris-Est Creteil University, 94000 Créteil, France; F-CRIN GRACE : French Clinical Research Infrastructure Network - Group for Research on Amyloidosis, Toulouse, France

Source PDF DOI Publisher page
133 days

Real-world persistence with sacubitril/valsartan in patients with heart failure in France: A claims database study

AuthorsOlivier Hanon; Ariel Cohen; Patrick Jourdain; Emmanuelle Leray; Gérard de Pouvourville; Mélanie Goguillot; Géraldine Hugon; Ribal Al-Mawla; Stéphanie Duret; Damien Logeart

AffiliationsGériatrie, université de Paris Cité, UMR S-1144, AP–HP, Hôpitaux Universitaires Paris Centre, hôpital Broca, 75013 Paris, France; Cardiologie, AP–HP, hôpital Saint-Antoine, Sorbonne université, 75012 Paris, France; Cardiologie, Ramsay Santé, 75017 Paris, France; Univ Rennes, EHESP, CNRS, Inserm, ARENES UMR 6051, RSMS U 1309, 35000 Rennes, France; Department of Economics, ESSEC Business School, 95000 Cergy-Pontoise, France; RWE, stève consultants, a Cytel company, 69600 Oullins-Pierre-Bénite, France; Medical affairs, Novartis, 92500 Rueil-Malmaison, France; RWE Advisor, Novartis, 92500 Rueil-Malmaison, France; Cardiologie, université de Paris Cité, AP–HP, hôpital Lariboisière, 75010 Paris, France

Source PDF DOI Publisher page
194 days

Contemporary management of patients with native mitral regurgitation in heart valve centres

AuthorsAugustin Coisne; Andrea Scotti; Yohann Bohbot; Julien Dreyfus; Anne Bernard; Yoan Lavie Badie; Natacha Rousse; Arnaud Sudre; Christophe Tribouilloy; Marcel Peltier; Sebastian Ludwig; Bertrand Marcheix; Damien Eyharts; Matthieu Steinecker; Mohammed Nejjari; Marie Luciani; Christophe Saint Etienne; Julien Ternacle; Guillaume Bonnet; Guillaume L’Official; Elena Galli; Patrizio Lancellotti; Juan Granada; Erwan Donal; Thomas Modine

AffiliationsUniversité de Lille, Inserm, CHU de Lille, Institut Pasteur de Lille, U1011-EGID, 59000 Lille, France; Cardiovascular Research Foundation, New York, NY 10019, USA; Montefiore-Einstein Center for Heart and Vascular Care, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10467, USA; Department of Cardiology, Amiens University Hospital, 80054 Amiens, France; UR UPJV 7517, Jules-Verne University of Picardie, 80054 Amiens, France; Cardiology Department, Centre Cardiologique du Nord, 93200 Saint-Denis, France; Service de Cardiologie, CHRU de Tours, 37000 Tours, France; EA4245, Loire Valley Cardiovascular Collaboration, Université de Tours, 37000 Tours, France; Heart Valve Center, Toulouse University Hospital, 31400 Toulouse, France; Department of Cardiology, University Heart and Vascular Center Hamburg, 52 20246 Hamburg, Germany; UMCV, Hôpital Cardiologique Haut-Lévêque, CHU de Bordeaux, 33600 Pessac, France; Quebec Heart and Lung Institute, Quebec G1V 4G5, Canada; Cardiologie, CHU de Rennes, LTSI, Inserm 1099, 35000 Rennes, France; University of Liège Hospital, GIGA Cardiovascular Sciences, Departments of Cardiology, Heart Valve Clinic, CHU Sart Tilman, 4000 Liège, Belgium; Gruppo Villa Maria Care and Research, Maria Cecilia Hospital, Cotignola, and Anthea Hospital, 48033 Bari, Italy

Source PDF DOI Publisher page
203 days

Allocation and prognosis of temporary mechanical circulatory support in unselected cardiogenic shock: Insights from the FRENSHOCK registry

AuthorsStéphane Manzo-Silberman; Vincent Bataille; Laurent Bonello; François Roubille; Bernard Levy; Pascal Lim; Guillaume Schurtz; Philippe Letocart; Karim Chaoui; Vincent Probst; Emile Ferrari; Olivier Delhaye; Raphael Favory; Meyer Elbaz; Edouard Gerbaud; Eric Bonnefoy; Etienne Puymirat; Guillaume Leurent; Clement Delmas

AffiliationsSorbonne University, Institute of Cardiology, Hôpital Pitié-Salpêtrière, AP–HP, ACTION Study Group, 75013 Paris, France; Fédération des Services de Cardiologie, CHU de Toulouse, 31059 Toulouse, France; Association pour la Diffusion de la Médecine de Prévention, 31400 Toulouse, France; Aix-Marseille Université, 13385 Marseille, France; Intensive Care Unit, Department of Cardiology, Assistance publique–Hôpitaux de Marseille, Hôpital Nord, 13385 Marseille, France; Mediterranean Association for Research and Studies in Cardiology (MARS Cardio), 13015 Marseille, France; PhyMedExp, Cardiology Department, Université de Montpellier, Inserm, CNRS, INI-CRT, CHU de Montpellier, 34295 Montpellier, France; Medical Intensive Care Unit, Brasbois, CHU de Nancy, 54000 Nancy, France; Intensive Cardiac Care Unit, Cardiology Department, AP–HP, Hôpital Henri-Mondor, 94010 Créteil, France; USIC Urgences, Centre Hémodynamique, Institut Cœur Poumon, Centre Hospitalier Universitaire Soins Intensifs de Cardiologie, CHU de Lille, University of Lille, Inserm U1167, 59000 Lille, France; Intensive Care Unit, CH Jacques-Puel, 12027 Rodez, France; Intensive Care Unit, CH de Cahors, 46000 Cahors, France; CHU de Nantes, 44000 Nantes, France; Hôpital Pasteur, CHU de Nice, 06001 Nice, France; Université de Nice Sofia Antipolis, 06103 Nice, France; Hopital Privé Le Blois Lille, 59003 Lille, France; Lille Hopital Roger-Salengro, 59000 Lille, France; Intensive Cardiac Care Unit and Interventional Cardiology, CHU de Bordeaux, Hôpital Cardiologique de Haut Levêque, Institut Hospitalo-Universitaire Liryc, Electrophysiology and Heart Modeling Institute, 33604 Pessac, France; Bordeaux Cardio-Thoracic Research Centre, CRTCB, Inserm U1045, Bordeaux University, 33600 Pessac, France; Intensive Cardiac Care Unit, Cardiology Department, Hospice Civils de Lyon, Hôpital Lyon-Brom, 69500 Lyon, France; Intensive Cardiac Care Unit, Cardiology Department, AP–HP, Hôpital Européen Georges-Pompidou, 75015 Paris, France; Université Rennes 1, Department of Cardiology, CHU de Rennes, Inserm, LTSI, UMR 1099, 35000 Rennes, France; Université Paul-Sabatier, Toulouse 3, 31000 Toulouse, France; Recherche Enseignement en Insuffisance Cardiaque Avancée Transplantation et Assistance (REICATRA), Institut Saint-Jacques, 31300 Toulouse, France

Source PDF DOI Publisher page
95 days

Transcatheter aortic valve implantation-related vascular access complications: Are balloon-expandable stent grafts a good option?

AuthorsGabriel Saiydoun; Romain Gallet; Saadé Saadé; Madjid Boukantar; Camille Brasselet; Paul-Mathieu Chiaroni; Costin Radu; Nicolas Lellouche; Ziyad Gunga; Thierry Folliguet; Emmanuel Teiger

AffiliationsDepartment of Cardiac and Thoracic Surgery, Pitié-Salpêtrière Hospital, Sorbonne University, AP–HP, 75013 Paris, France; Department of Cardiac Surgery, Henri Mondor university hospital, AP–HP, 94000 Créteil, France; Department of Cardiology, Henri-Mondor university hospital, AP–HP, 94000 Créteil, France; Department of Cardiac Surgery, Strasbourg University hospital, 67000 Strasbourg, France; Department of Cardiac Surgery, Lausanne University Hospital, University of Lausanne, 1011 Lausanne, Switzerland

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.